Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

Competition cop Lina Khan’s antitrust overreach is hurting U.S. competitiveness–and destroying billions of dollars in value

Antitrust overreach is hurting America's global competitiveness, with the FTC calculating industry concentration on a purely domestic basis.

Fortune

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning

Biogen and Eisai scored key victories in the quest for an Alzheimer's cure. But the race is just getting started.

Investors Business Daily

November Buy Alert: 3 Biotech Stocks Making Gains

Given the breakthrough developments and the rising need to treat chronic diseases, the biotech industry is well-positioned to generate returns. This might make buying biotech stocks like Organogenesis Holdings (ORGO), Innoviva (INVA), and Amgen (AMGN) a wise decision this November. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Amgen Tumbles After Scrapping A $900 Million Prostate Cancer Drug

Amgen handily beat earnings forecasts Tuesday, but Amgen stock tumbled after the company scrapped an experimental prostate cancer treatment.

Investors Business Daily

Dow Jones Falls 125 Points After Key Housing Data; Caterpillar Dives On Earnings

The Dow Jones Industrial Average dropped 125 points Tuesday after key housing data. Tesla stock continued to slide after Monday's dive.

Investors Business Daily

Amgen (AMGN) Earnings Watch: Buy or Sell?

Amgen (AMGN) is scheduled to report its third-quarter earnings soon, with Wall Street analysts expecting year-over-year improvements in revenue. However, its earnings are expected to miss the consensus estimate. Moreover, the company completed the acquisition of Horizon Therapeutics earlier this month. Considering these factors, is the stock a buy or…

StockNews.com

Microsoft Leads These 5 Dow Jones Stocks Near Buy Points

Microsoft, one of just two Magnificent Seven stocks to move higher last week, leads this watchlist of five Dow Jones stocks. near buy points.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Amgen cuts Horizon Therapeutics jobs at Deerfield office after acquisition

350 people will be laid off, many of them at Horizon’s U.S. base in Deerfield.

Chicago Sun-Times

How to Enhance Your Own Strategies with POWR Ratings

Wall Street is never lacking in strategy or trading ideas. In investing, if you can combine two or more strategies that align around a particular investing idea, you can enhance your likelihood of success. This idea combines our POWR Ratings with a strategy that is currently making the rounds on…

StockNews.com

Dow Jones Rises After Fed Minutes; Meta Breaks Out

Dow Jones rose after the Fed meeting minutes for September were released and the House planned to vote on a new speaker. Meta broke out.

Investors Business Daily

Amgen Stock Surges To 10-Month High, Up 5% On An Unexpected Upgrade

Amgen stock snagged an upgrade Wednesday and surged to a 10-month high as one analyst examined the biotech behemoth's post-Horizon future.

Investors Business Daily

Mirati Therapeutics Snags $5.8 Billion Takeover Deal, But Shares Fall On Lowball Price

Bristol Myers Squibb offered to buy Mirati Therapeutics for up to $5.8 billion, but MRTX stock tumbled on the lowball price.

Investors Business Daily

All in: Drugmakers say yes, they'll negotiate with Medicare on price, so reluctantly

Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will come to the bargaining table.

WEKU

Dow Jones Falls 150 Points After Shutdown Averted; Tesla Stock Slides On Weak Deliveries

The Dow Jones fell 150 points Monday, as the U.S. government averted a shutdown. Tesla stock slid on weak Q3 deliveries.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rallies 200 Points On Cool Inflation Data; Nike Surges On Earnings

The Dow Jones Industrial Average rallied 200 points Friday on a cool inflation report. Nike stock surged on strong earnings results.

Investors Business Daily

Dow Jones Reverses After Jobless Claims, Weak GDP; CarMax Dives On Earnings

The Dow Jones reversed Thursday on initial jobless claims and weak GDP. Used-car retailer CarMax dived on earnings.

Investors Business Daily

Dow Jones Falls After Key Economic Data; Costco Rallies On Earnings

The Dow Jones Industrial Average reversed lower Wednesday after key economic data. Costco stock rallied on strong earnings results.

Investors Business Daily

Dow Jones Slides 250 Points Amid Housing Data; DraftKings Pops On Upgrade

The Dow Jones slid 250 points Tuesday after key housing data. DraftKings rose on an analyst upgrade, while Tesla stock skidded.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall: Key Inflation Data Looms As Yields Jump; Tesla Stock In Focus Ahead Of Deliveries

Dow Jones futures: Key inflation data looms this week, while Tesla stock is in focus ahead of the EV giant's Q3 deliveries.

Investors Business Daily

Dow Jones Falls As Market Correction Worsens; 10-Year Treasury Spikes To New High

The Dow Jones Industrial Average dropped Monday, as the market correction worsens. The 10-year Treasury yield spikes to new highs.

Investors Business Daily

Stocks Fall As Oil Nears $100 Per Barrel; Instacart Soars In Debut

Dow Jones fell ahead of the Fed meeting. Instacart jumped on its debut on the Nasdaq.

StockNews.com

3 Healthcare Stocks to Buy Today

The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV).

Investors Business Daily

Amgen Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold

Amgen sees its Relative Strength Rating enter the 80-plus level.

Fortune

Alphabet's Wing CFO Shannon Nash shares her unique path to the C-suite

Nash, who is also an award-winning film producer, names Debbie Allen as one of her greatest mentors.

Investors Business Daily

Why Amgen's $28 Billion Merger News Also Bodes Well For Pfizer, Biogen

Amgen stock rose Friday after the FTC dropped its lawsuit, clearing the way for the biotech to buy Horizon Therapeutics for $28 billion.

1 … 5 6 7 8

People

Joe Biden

64,469 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations